Miraflash
21 NAFDAC-registered products in Nigeria
Independent profile. This page is compiled by Ogbogwu from NAFDAC-registered records and public information. Ogbogwu is not affiliated with Miraflash, and this listing does not imply any endorsement or partnership.
About Miraflash
Miraflash has 21 products registered with NAFDAC for the Nigerian market. The full list below is compiled from the NAFDAC Greenbook — Nigeria's official register of approved products.
Miraflash products registered in Nigeria
All 21 NAFDAC-registered products. Filter by therapeutic area, or search by name or ingredient. Products we have a full guide for link through to uses, dosage, price, and verification.
21 of 21 products
| Product | Active ingredient | Strength | Form | NAFDAC No. |
|---|---|---|---|---|
| Cephaflash Capsules | Cefalexin | 500 mg | Capsule | B4-5534 |
| Fladinir 125 mg Suspension | Cefdinir | 125 mg/5 mL | Suspension | A11-100596 |
| Fladinir Capsule 300 mg** | Cefdinir | 300 mg | Capsule | A11-1023 |
| Miraclox Capsules | Ampicillin (Ampicillin Trihydrate); Cloxacillin (Cloxacillin Sodium) | 250 mg; 250 mg | Capsule | A11-0038 |
| Miradroxil 125 mg Suspension | Cefadroxil | 125 mg/5 mL | Suspension | A11-100598 |
| Miradroxil 250 mg Suspension | Cefadroxil | 250 mg/5 mL | Suspension | A11-100597 |
| Miradroxil 500 mg Capsule | Cefadroxil | 500 mg | Capsule | A11-1005 |
| Mirafix 400 mg Capsule** | Cefixime (Cefixime Trihydrate) | 400 mg | Capsule | A11-1020 |
| Mirafix Oral Suspension | Cefixime (Cefixime Trihydrate) | 50 mg/5 mL | Suspension | B4-5532 |
| Mirafix-200 Capsules | Cefixime (Cefixime Trihydrate) | 200 mg | Capsule | B4-5535 |
| Miraflash Vitamin C | Vitamin C (Ascorbic Acid) | 100 mg | Tablet | A11-100589 |
| Miramox Capsules | Amoxicillin | 500 mg | Capsule | B4-5536 |
| Mirapicin Capsules | Ampicillin (Ampicillin Trihydrate) | 125 mg/5 mL | Capsule | 04-6868 |
| Mirapicin Capsules | Ampicillin (Ampicillin Trihydrate) | 250 mg | Capsule | B4-5538 |
| Mirapicin Capsules | Ampicillin (Ampicillin Trihydrate) | 125 mg/5 mL | Capsule | 04-6868 |
| Miraxim Capsules | Cefuroxime (Cefuroxime Axetil) | 250 mg | Capsule | B4-5537 |
| Miraxim Suspension | Cefuroxime (Cefuroxime Axetil) | 125 mg/5 mL | Suspension | B4-5533 |
| Mospodox 100 mg/5 mL Suspension | Cefpodoxime (Cefpodoxime Proxetil) | 100 mg | Suspension | A11-0875 |
| Mospodox 200 mg Capsule | Cefpodoxime (Cefpodoxime Proxetil) | 200 mg | Capsule | A11-0859 |
| Mospodox 50 mg/5 mLSuspension | Cefpodoxime (Cefpodoxime Proxetil) | 50 mg/5 mL | Suspension | A11-0860 |
| Tridermix-G Cream | Betamethasone; Tolnaftate; Neomycin sulfate; Clioquinol | 0.05%; 1%; 0.5%; 1% | Cream | A4-5900 |
Is this your company?
If you represent Miraflash, you can claim this page to keep your company details current, or flag anything that needs correcting. Product and NAFDAC registration facts stay independently maintained by Ogbogwu.
Opens a WhatsApp chat with our team, with your message pre-filled.
Sources
- •NAFDAC Greenbook — the official database of products registered with Nigeria's National Agency for Food and Drug Administration and Control. The product list for Miraflash is drawn from active registrations in the Greenbook.